Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Jan;80(1):46–50. doi: 10.1136/adc.80.1.46

Androgen secreting adrenocortical tumours

O Wolthers 1, F Cameron 1, I Scheimberg 1, J Honour 1, P Hindmarsh 1, M Savage 1, R Stanhope 1, C Brook 1
PMCID: PMC1717797  PMID: 10325758

Abstract

BACKGROUND—Androgen secreting adrenocortical tumours are rare in children and the determination of their malignant potential can be difficult.
OBJECTIVES—To assess the presentation, histology, and clinical behaviour of these tumours.
SETTING—Two tertiary referral centres. 
Study design—Retrospective analysis of children diagnosed with an androgen secreting adrenocortical tumour between 1976 and 1996.
PATIENTS—Twenty three girls and seven boys aged 0-14 years.
RESULTS—Pubic hair was observed in all children, clitoromegaly or growth of the phallus in 23 children, acceleration of linear growth in 22 children, and advanced bone age (> 1.5 years) in 18 children. Hypersecretion of androgens was detected by assessment of serum androgen concentrations alone in four patients and by 24 hour urine steroid excretion profiles in 22 patients. All 16 tumours measuring < 5 cm in diameter were benign. Of the tumours measuring 5-9 cm, three were malignant and seven were benign, whereas all four tumours > 10 cm were malignant. Histological slides were available for reassessment in 25 children. Although mitoses and necrosis were more characteristic of tumours with malignant behaviour, no exclusive histological features of malignancy were seen.
CONCLUSION—Histological criteria for malignancy are not reliable, whereas tumour size is important in assessing malignant potential.



Full Text

The Full Text of this article is available as a PDF (208.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergadá I., Venara M., Maglio S., Ciaccio M., Diez B., Bergadá C., Chemes H. Functional adrenal cortical tumors in pediatric patients: a clinicopathologic and immunohistochemical study of a long term follow-up series. Cancer. 1996 Feb 15;77(4):771–777. [PubMed] [Google Scholar]
  2. Bugg M. F., Ribeiro R. C., Roberson P. K., Lloyd R. V., Sandrini R., Silva J. B., Epelman S., Shapiro D. N., Parham D. M. Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. Am J Clin Pathol. 1994 May;101(5):625–629. doi: 10.1093/ajcp/101.5.625. [DOI] [PubMed] [Google Scholar]
  3. Burrington J. D., Stephens C. A. Virilizing tumors of the adrenal gland in childhood: report of eight cases. J Pediatr Surg. 1969 Jun;4(3):291–302. doi: 10.1016/0022-3468(69)90674-5. [DOI] [PubMed] [Google Scholar]
  4. Cagle P. T., Hough A. J., Pysher T. J., Page D. L., Johnson E. H., Kirkland R. T., Holcombe J. H., Hawkins E. P. Comparison of adrenal cortical tumors in children and adults. Cancer. 1986 Jun 1;57(11):2235–2237. doi: 10.1002/1097-0142(19860601)57:11<2235::aid-cncr2820571127>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  5. Chudler R. M., Kay R. Adrenocortical carcinoma in children. Urol Clin North Am. 1989 Aug;16(3):469–479. [PubMed] [Google Scholar]
  6. Gabrilove J. L., Seman A. T., Sabet R., Mitty H. A., Nicolis G. L. Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature. Endocr Rev. 1981 Fall;2(4):462–470. doi: 10.1210/edrv-2-4-462. [DOI] [PubMed] [Google Scholar]
  7. Haak H. R., Hermans J., van de Velde C. J., Lentjes E. G., Goslings B. M., Fleuren G. J., Krans H. M. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer. 1994 May;69(5):947–951. doi: 10.1038/bjc.1994.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Halmi K. A., Lascari A. D. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma. Cancer. 1971 Apr;27(4):931–935. doi: 10.1002/1097-0142(197104)27:4<931::aid-cncr2820270426>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Honour J. W., Price D. A., Taylor N. F., Marsden H. B., Grant D. B. Steroid biochemistry of virilising adrenal tumours in childhood. Eur J Pediatr. 1984 Aug;142(3):165–169. doi: 10.1007/BF00442442. [DOI] [PubMed] [Google Scholar]
  10. Hough A. J., Hollifield J. W., Page D. L., Hartmann W. H. Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am J Clin Pathol. 1979 Sep;72(3):390–399. doi: 10.1093/ajcp/72.3.390. [DOI] [PubMed] [Google Scholar]
  11. Latronico A. C., Chrousos G. P. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab. 1997 May;82(5):1317–1324. doi: 10.1210/jcem.82.5.3921. [DOI] [PubMed] [Google Scholar]
  12. Lee P. D., Winter R. J., Green O. C. Virilizing adrenocortical tumors in childhood: eight cases and a review of the literature. Pediatrics. 1985 Sep;76(3):437–444. [PubMed] [Google Scholar]
  13. Marx C., Wolkersdörfer G. W., Brown J. W., Scherbaum W. A., Bornstein S. R. MHC class II expression--a new tool to assess dignity in adrenocortical tumours. J Clin Endocrinol Metab. 1996 Dec;81(12):4488–4491. doi: 10.1210/jcem.81.12.8954065. [DOI] [PubMed] [Google Scholar]
  14. McWhirter W. R., Stiller C. A., Lennox E. L. Carcinomas in childhood. A registry-based study of incidence and survival. Cancer. 1989 Jun 1;63(11):2242–2246. doi: 10.1002/1097-0142(19890601)63:11<2242::aid-cncr2820631131>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  15. Mendonca B. B., Lucon A. M., Menezes C. A., Saldanha L. B., Latronico A. C., Zerbini C., Madureira G., Domenice S., Albergaria M. A., Camargo M. H. Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. J Urol. 1995 Dec;154(6):2004–2009. [PubMed] [Google Scholar]
  16. Nasir J., Walton C. Adrenal mass with virilisation: importance of endocrine investigation. BMJ. 1996 Oct 5;313(7061):872–873. doi: 10.1136/bmj.313.7061.872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ribeiro R. C., Sandrini Neto R. S., Schell M. J., Lacerda L., Sambaio G. A., Cat I. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol. 1990 Jan;8(1):67–74. doi: 10.1200/JCO.1990.8.1.67. [DOI] [PubMed] [Google Scholar]
  18. Sandrini R., Ribeiro R. C., DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997 Jul;82(7):2027–2031. doi: 10.1210/jcem.82.7.4057. [DOI] [PubMed] [Google Scholar]
  19. Schlumberger M., Ostronoff M., Bellaiche M., Rougier P., Droz J. P., Parmentier C. 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer. 1988 Apr 15;61(8):1492–1494. doi: 10.1002/1097-0142(19880415)61:8<1492::aid-cncr2820610803>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  20. Tsukamoto T., Kumamoto Y., Takahashi A., Akagashi K., Itoh N., Nanbu A., Sato M. Adrenocortical carcinoma in a child with specific pedigree of family associated with cancer aggregation. J Urol. 1992 Jan;147(1):104–106. doi: 10.1016/s0022-5347(17)37146-x. [DOI] [PubMed] [Google Scholar]
  21. Young J. L., Jr, Miller R. W. Incidence of malignant tumors in U. S. children. J Pediatr. 1975 Feb;86(2):254–258. doi: 10.1016/s0022-3476(75)80484-7. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES